Cargando…

Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma

BACKGROUNDS: SET and MYND domain-containing protein 2 (SMYD2), which is identified as a protein-lysine methyltransferase, plays a crucial role in the progression of some tumors such as bladder carcinoma. However, the clinical significance of SMYD2 in patients with papillary thyroid carcinoma (PTC) h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wenchao, Chen, Fulian, Fei, Xiao, Yang, Xiaoqing, Lu, Xiaofei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198713/ https://www.ncbi.nlm.nih.gov/pubmed/30319138 http://dx.doi.org/10.12659/MSM.910168

Ejemplares similares

SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer
por: Liu, Ting-Ting, et al.
Publicado: (2016)

Is MYND Domain-Mediated Assembly of SMYD3 Complexes Involved in Calcium Dependent Signaling?
por: Zhang, Yingxue, et al.
Publicado: (2019)

Structure and Function of SET and MYND Domain-Containing Proteins
por: Spellmon, Nicholas, et al.
Publicado: (2015)

Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer
por: Alshammari, Eid, et al.
Publicado: (2022)

Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
por: Brown, Mark A, et al.
Publicado: (2006)

SET and MYND domain-containing protein 3 inhibits tumor cell sensitivity to cisplatin
por: Wang, Lei, et al.
Publicado: (2020)

EZH2 and SMYD3 expression in papillary thyroid cancer
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

Dynamin 2 Is Correlated with Recurrence and Poor Prognosis of Papillary Thyroid Cancer
por: Ren, Ning, et al.
Publicado: (2020)

Structural and Functional Analysis of the DEAF-1 and BS69 MYND Domains
por: Kateb, Fatiha, et al.
Publicado: (2013)

Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
por: Zuo, Shan-Ru, et al.
Publicado: (2018)

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
por: Komatsu, S, et al.
Publicado: (2015)

SET/MYND Lysine Methyltransferases Regulate Gene Transcription and Protein Activity
por: Leinhart, Kristin, et al.
Publicado: (2011)

SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Li, Jing, et al.
Publicado: (2020)

Expression of WD Repeat Domain 5 (WDR5) is Associated with Progression and Reduced Prognosis in Papillary Thyroid Carcinoma
por: Xu, Wenchao, et al.
Publicado: (2019)

Localization of a Guanylyl Cyclase to Chemosensory Cilia Requires the Novel Ciliary MYND Domain Protein DAF-25
por: Jensen, Victor L., et al.
Publicado: (2010)

AP-2α expression in papillary thyroid carcinoma predicts tumor progression and poor prognosis
por: Wu, Hong Rong, et al.
Publicado: (2018)

Overexpression of G Protein-Coupled Receptor Kinase 6 (GRK6) Is Associated with Progression and Poor Prognosis of Papillary Thyroid Carcinoma
por: Che, Xiaoqi, et al.
Publicado: (2018)

Overexpression of novel long intergenic non-coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer
por: Tan, Juan, et al.
Publicado: (2020)

HIF1A overexpression predicts the high lymph node metastasis risk and indicates a poor prognosis in papillary thyroid cancer
por: Zhao, Yong-xun, et al.
Publicado: (2023)

Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas
por: Lin, Shaojun, et al.
Publicado: (2014)

Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis
por: Ma, Shao-Jun, et al.
Publicado: (2018)

Upregulation of sphingosine kinase 1 is associated with recurrence and poor prognosis in papillary thyroid carcinoma
por: Li, Jie, et al.
Publicado: (2019)

Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma
por: Ding, Jinhua, et al.
Publicado: (2020)

Smyd2 conformational changes in response to p53 binding: role of the C‐terminal domain
por: Chandramouli, Balasubramanian, et al.
Publicado: (2019)

Overexpression of Pleckstrin Homology Domain-Containing Family A Member 4 Is Correlated with Poor Prognostic Outcomes and Immune Infiltration in Lower-Grade Glioma
por: Huang, Baojun, et al.
Publicado: (2022)

PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma
por: Qian, Zhaoye, et al.
Publicado: (2019)

Prognosis of Multifocal Papillary Thyroid Carcinoma
por: Kuo, Sheng-Fong, et al.
Publicado: (2013)

SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells
por: Toghill, Bradley J., et al.
Publicado: (2018)

Expression of Spindle and Kinetochore-Associated Protein 1 Is Associated with Poor Prognosis in Papillary Thyroid Carcinoma
por: Dong, Chao, et al.
Publicado: (2015)

Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
por: Shen, Lei, et al.
Publicado: (2018)

Trop2 is overexpressed in gastric cancer and predicts poor prognosis
por: Zhao, Wei, et al.
Publicado: (2015)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
por: Lu, Wenjie, et al.
Publicado: (2020)

SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

Overexpression of fibronectin type III domain containing 3B is correlated with epithelial-mesenchymal transition and predicts poor prognosis in lung adenocarcinoma
por: Bian, Tingting, et al.
Publicado: (2019)

SMYD2 glutathionylation contributes to degradation of sarcomeric proteins
por: Munkanatta Godage, Dhanushka N. P., et al.
Publicado: (2018)

Histone methyltransferase SMYD2: ubiquitous regulator of disease
por: Yi, Xin, et al.
Publicado: (2019)

Domain swapping and SMYD1 interactions with the PWWP domain of human hepatoma-derived growth factor
por: Chen, Li-Ying, et al.
Publicado: (2018)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_csfkcr6k7s3rmjj2k5hjuqkme0